星空体育官方入口网站网址大全-登录入口官网

[GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216383, encodeId=e2a42216383d8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏代谢 经验分享：请问各位前辈，二审要多久？Article大修后提交了10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81b61669375, createdName=黑色音符, createdTime=Tue Jul 23 09:41:14 CST 2024, time=2024-07-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212400, encodeId=134a22124001f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：主编华人教授，对国人非常友好，审稿周期1个月，修回5天接收，效率非常高的一个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Sun Jun 30 09:12:46 CST 2024, time=2024-06-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210096, encodeId=8edf22100968d, content=偏重的研究方向：肝纤维化 经验分享：2024-6-15 submit 目前一直还是received状态，后续会继续更新，期待能送外审，不然下一本杂志不知道选啥了，因为12月初之前需要接收，不然工作就黄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac285555037, createdName=张辣辣, createdTime=Sat Jun 15 23:41:19 CST 2024, time=2024-06-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208509, encodeId=a8fe2208509c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤 经验分享：二审时间真的看不懂，有的人几天就出来了，有的要等几个月。文章也好多都是人情帐。好的差的差别特别大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22eb8584821, createdName=ms6000000663577427, createdTime=Wed Jun 05 21:03:05 CST 2024, time=2024-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2208075, encodeId=bf0e22080e5a5, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Jun 03 16:51:17 CST 2024, time=2024-06-03, status=1, ipAttribution=广东省)]

2022-02-23 悬崖听风007

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤免疫
经验分享：Received 2021-12-16 from IP
Minor revision 2022-2-8
Received 2022-2-17 from IP
Final accept 2022-2-22
Pre-publish-fee 2022-2-22
投稿到接受2个月零几天，效率杠杠的。感恩。

101 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216383, encodeId=e2a42216383d8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏代谢 经验分享：请问各位前辈，二审要多久？Article大修后提交了10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81b61669375, createdName=黑色音符, createdTime=Tue Jul 23 09:41:14 CST 2024, time=2024-07-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212400, encodeId=134a22124001f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：主编华人教授，对国人非常友好，审稿周期1个月，修回5天接收，效率非常高的一个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Sun Jun 30 09:12:46 CST 2024, time=2024-06-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210096, encodeId=8edf22100968d, content=偏重的研究方向：肝纤维化 经验分享：2024-6-15 submit 目前一直还是received状态，后续会继续更新，期待能送外审，不然下一本杂志不知道选啥了，因为12月初之前需要接收，不然工作就黄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac285555037, createdName=张辣辣, createdTime=Sat Jun 15 23:41:19 CST 2024, time=2024-06-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208509, encodeId=a8fe2208509c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤 经验分享：二审时间真的看不懂，有的人几天就出来了，有的要等几个月。文章也好多都是人情帐。好的差的差别特别大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22eb8584821, createdName=ms6000000663577427, createdTime=Wed Jun 05 21:03:05 CST 2024, time=2024-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2208075, encodeId=bf0e22080e5a5, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Jun 03 16:51:17 CST 2024, time=2024-06-03, status=1, ipAttribution=广东省)]

2024-07-23 黑色音符来自江苏省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肝脏代谢
经验分享：请问各位前辈，二审要多久？Article大修后提交了10天了

7 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216383, encodeId=e2a42216383d8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏代谢 经验分享：请问各位前辈，二审要多久？Article大修后提交了10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81b61669375, createdName=黑色音符, createdTime=Tue Jul 23 09:41:14 CST 2024, time=2024-07-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212400, encodeId=134a22124001f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：主编华人教授，对国人非常友好，审稿周期1个月，修回5天接收，效率非常高的一个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Sun Jun 30 09:12:46 CST 2024, time=2024-06-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210096, encodeId=8edf22100968d, content=偏重的研究方向：肝纤维化 经验分享：2024-6-15 submit 目前一直还是received状态，后续会继续更新，期待能送外审，不然下一本杂志不知道选啥了，因为12月初之前需要接收，不然工作就黄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac285555037, createdName=张辣辣, createdTime=Sat Jun 15 23:41:19 CST 2024, time=2024-06-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208509, encodeId=a8fe2208509c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤 经验分享：二审时间真的看不懂，有的人几天就出来了，有的要等几个月。文章也好多都是人情帐。好的差的差别特别大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22eb8584821, createdName=ms6000000663577427, createdTime=Wed Jun 05 21:03:05 CST 2024, time=2024-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2208075, encodeId=bf0e22080e5a5, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Jun 03 16:51:17 CST 2024, time=2024-06-03, status=1, ipAttribution=广东省)]

2024-06-30 zhuimengzhe 来自江苏省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：主编华人教授，对国人非常友好，审稿周期1个月，修回5天接收，效率非常高的一个期刊。

42 0

[GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216383, encodeId=e2a42216383d8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏代谢 经验分享：请问各位前辈，二审要多久？Article大修后提交了10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81b61669375, createdName=黑色音符, createdTime=Tue Jul 23 09:41:14 CST 2024, time=2024-07-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212400, encodeId=134a22124001f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：主编华人教授，对国人非常友好，审稿周期1个月，修回5天接收，效率非常高的一个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Sun Jun 30 09:12:46 CST 2024, time=2024-06-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210096, encodeId=8edf22100968d, content=偏重的研究方向：肝纤维化 经验分享：2024-6-15 submit 目前一直还是received状态，后续会继续更新，期待能送外审，不然下一本杂志不知道选啥了，因为12月初之前需要接收，不然工作就黄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac285555037, createdName=张辣辣, createdTime=Sat Jun 15 23:41:19 CST 2024, time=2024-06-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208509, encodeId=a8fe2208509c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤 经验分享：二审时间真的看不懂，有的人几天就出来了，有的要等几个月。文章也好多都是人情帐。好的差的差别特别大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22eb8584821, createdName=ms6000000663577427, createdTime=Wed Jun 05 21:03:05 CST 2024, time=2024-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2208075, encodeId=bf0e22080e5a5, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Jun 03 16:51:17 CST 2024, time=2024-06-03, status=1, ipAttribution=广东省)]

2021-06-03 ms6000000669997524

偏重的研究方向：细胞;分子生物学
经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗

163 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216383, encodeId=e2a42216383d8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏代谢 经验分享：请问各位前辈，二审要多久？Article大修后提交了10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81b61669375, createdName=黑色音符, createdTime=Tue Jul 23 09:41:14 CST 2024, time=2024-07-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212400, encodeId=134a22124001f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：主编华人教授，对国人非常友好，审稿周期1个月，修回5天接收，效率非常高的一个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Sun Jun 30 09:12:46 CST 2024, time=2024-06-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210096, encodeId=8edf22100968d, content=偏重的研究方向：肝纤维化 经验分享：2024-6-15 submit 目前一直还是received状态，后续会继续更新，期待能送外审，不然下一本杂志不知道选啥了，因为12月初之前需要接收，不然工作就黄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac285555037, createdName=张辣辣, createdTime=Sat Jun 15 23:41:19 CST 2024, time=2024-06-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208509, encodeId=a8fe2208509c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤 经验分享：二审时间真的看不懂，有的人几天就出来了，有的要等几个月。文章也好多都是人情帐。好的差的差别特别大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22eb8584821, createdName=ms6000000663577427, createdTime=Wed Jun 05 21:03:05 CST 2024, time=2024-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2208075, encodeId=bf0e22080e5a5, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Jun 03 16:51:17 CST 2024, time=2024-06-03, status=1, ipAttribution=广东省)]

2022-11-21 503616919

偏重的研究方向：肿瘤;基因功能
经验分享：11-16 投 11-21 replace消失期待外审

84 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216383, encodeId=e2a42216383d8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏代谢 经验分享：请问各位前辈，二审要多久？Article大修后提交了10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81b61669375, createdName=黑色音符, createdTime=Tue Jul 23 09:41:14 CST 2024, time=2024-07-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212400, encodeId=134a22124001f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：主编华人教授，对国人非常友好，审稿周期1个月，修回5天接收，效率非常高的一个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Sun Jun 30 09:12:46 CST 2024, time=2024-06-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210096, encodeId=8edf22100968d, content=偏重的研究方向：肝纤维化 经验分享：2024-6-15 submit 目前一直还是received状态，后续会继续更新，期待能送外审，不然下一本杂志不知道选啥了，因为12月初之前需要接收，不然工作就黄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac285555037, createdName=张辣辣, createdTime=Sat Jun 15 23:41:19 CST 2024, time=2024-06-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208509, encodeId=a8fe2208509c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤 经验分享：二审时间真的看不懂，有的人几天就出来了，有的要等几个月。文章也好多都是人情帐。好的差的差别特别大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22eb8584821, createdName=ms6000000663577427, createdTime=Wed Jun 05 21:03:05 CST 2024, time=2024-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2208075, encodeId=bf0e22080e5a5, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Jun 03 16:51:17 CST 2024, time=2024-06-03, status=1, ipAttribution=广东省)]

2024-01-21 ms1000001490330585 来自广东省

4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!

134 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216383, encodeId=e2a42216383d8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏代谢 经验分享：请问各位前辈，二审要多久？Article大修后提交了10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81b61669375, createdName=黑色音符, createdTime=Tue Jul 23 09:41:14 CST 2024, time=2024-07-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212400, encodeId=134a22124001f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：主编华人教授，对国人非常友好，审稿周期1个月，修回5天接收，效率非常高的一个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Sun Jun 30 09:12:46 CST 2024, time=2024-06-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210096, encodeId=8edf22100968d, content=偏重的研究方向：肝纤维化 经验分享：2024-6-15 submit 目前一直还是received状态，后续会继续更新，期待能送外审，不然下一本杂志不知道选啥了，因为12月初之前需要接收，不然工作就黄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac285555037, createdName=张辣辣, createdTime=Sat Jun 15 23:41:19 CST 2024, time=2024-06-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208509, encodeId=a8fe2208509c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤 经验分享：二审时间真的看不懂，有的人几天就出来了，有的要等几个月。文章也好多都是人情帐。好的差的差别特别大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22eb8584821, createdName=ms6000000663577427, createdTime=Wed Jun 05 21:03:05 CST 2024, time=2024-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2208075, encodeId=bf0e22080e5a5, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Jun 03 16:51:17 CST 2024, time=2024-06-03, status=1, ipAttribution=广东省)]

2024-06-15 张辣辣来自浙江省

偏重的研究方向：肝纤维化
经验分享：2024-6-15 submit 目前一直还是received状态，后续会继续更新，期待能送外审，不然下一本杂志不知道选啥了，因为12月初之前需要接收，不然工作就黄了。

59 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216383, encodeId=e2a42216383d8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏代谢 经验分享：请问各位前辈，二审要多久？Article大修后提交了10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81b61669375, createdName=黑色音符, createdTime=Tue Jul 23 09:41:14 CST 2024, time=2024-07-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212400, encodeId=134a22124001f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：主编华人教授，对国人非常友好，审稿周期1个月，修回5天接收，效率非常高的一个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Sun Jun 30 09:12:46 CST 2024, time=2024-06-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210096, encodeId=8edf22100968d, content=偏重的研究方向：肝纤维化 经验分享：2024-6-15 submit 目前一直还是received状态，后续会继续更新，期待能送外审，不然下一本杂志不知道选啥了，因为12月初之前需要接收，不然工作就黄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac285555037, createdName=张辣辣, createdTime=Sat Jun 15 23:41:19 CST 2024, time=2024-06-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208509, encodeId=a8fe2208509c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤 经验分享：二审时间真的看不懂，有的人几天就出来了，有的要等几个月。文章也好多都是人情帐。好的差的差别特别大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22eb8584821, createdName=ms6000000663577427, createdTime=Wed Jun 05 21:03:05 CST 2024, time=2024-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2208075, encodeId=bf0e22080e5a5, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Jun 03 16:51:17 CST 2024, time=2024-06-03, status=1, ipAttribution=广东省)]

2024-06-05 ms6000000663577427 来自江苏省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：分子生物学;肿瘤
经验分享：二审时间真的看不懂，有的人几天就出来了，有的要等几个月。文章也好多都是人情帐。好的差的差别特别大。

31 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216383, encodeId=e2a42216383d8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏代谢 经验分享：请问各位前辈，二审要多久？Article大修后提交了10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81b61669375, createdName=黑色音符, createdTime=Tue Jul 23 09:41:14 CST 2024, time=2024-07-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212400, encodeId=134a22124001f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：主编华人教授，对国人非常友好，审稿周期1个月，修回5天接收，效率非常高的一个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Sun Jun 30 09:12:46 CST 2024, time=2024-06-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210096, encodeId=8edf22100968d, content=偏重的研究方向：肝纤维化 经验分享：2024-6-15 submit 目前一直还是received状态，后续会继续更新，期待能送外审，不然下一本杂志不知道选啥了，因为12月初之前需要接收，不然工作就黄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac285555037, createdName=张辣辣, createdTime=Sat Jun 15 23:41:19 CST 2024, time=2024-06-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208509, encodeId=a8fe2208509c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤 经验分享：二审时间真的看不懂，有的人几天就出来了，有的要等几个月。文章也好多都是人情帐。好的差的差别特别大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22eb8584821, createdName=ms6000000663577427, createdTime=Wed Jun 05 21:03:05 CST 2024, time=2024-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2208075, encodeId=bf0e22080e5a5, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Jun 03 16:51:17 CST 2024, time=2024-06-03, status=1, ipAttribution=广东省)]

2024-04-17 ms5000000572045221 来自安徽省

大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急

1 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1196293, encodeId=be65119629314, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：Received 2021-12-16 from IP Minor revision 2022-2-8 Received 2022-2-17 from IP Final accept 2022-2-22 Pre-publish-fee 2022-2-22 投稿到接受2个月零几天，效率杠杠的。感恩。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F88E7670B394919.jpg, createdBy=4a021962386, createdName=悬崖听风007, createdTime=Wed Feb 23 08:03:34 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2216383, encodeId=e2a42216383d8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏代谢 经验分享：请问各位前辈，二审要多久？Article大修后提交了10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81b61669375, createdName=黑色音符, createdTime=Tue Jul 23 09:41:14 CST 2024, time=2024-07-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212400, encodeId=134a22124001f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：主编华人教授，对国人非常友好，审稿周期1个月，修回5天接收，效率非常高的一个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/57924E5C16B75765A5657F5A49C86350/100, createdBy=3c8a1985260, createdName=zhuimengzhe, createdTime=Sun Jun 30 09:12:46 CST 2024, time=2024-06-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101715, encodeId=44bc2101e15f5, content=偏重的研究方向：肿瘤;基因功能 经验分享：11-16 投 11-21 replace消失期待外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77734818981, createdName=503616919, createdTime=Mon Nov 21 09:26:19 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210096, encodeId=8edf22100968d, content=偏重的研究方向：肝纤维化 经验分享：2024-6-15 submit 目前一直还是received状态，后续会继续更新，期待能送外审，不然下一本杂志不知道选啥了，因为12月初之前需要接收，不然工作就黄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac285555037, createdName=张辣辣, createdTime=Sat Jun 15 23:41:19 CST 2024, time=2024-06-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208509, encodeId=a8fe2208509c9, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤 经验分享：二审时间真的看不懂，有的人几天就出来了，有的要等几个月。文章也好多都是人情帐。好的差的差别特别大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22eb8584821, createdName=ms6000000663577427, createdTime=Wed Jun 05 21:03:05 CST 2024, time=2024-06-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2208075, encodeId=bf0e22080e5a5, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Jun 03 16:51:17 CST 2024, time=2024-06-03, status=1, ipAttribution=广东省)]

2024-06-03 ms6000000294853759 来自广东省

1

38 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务